Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Xelaglifam - Yunovia

Next Previous
Drug Profile

Xelaglifam - Yunovia

Alternative Names: IDG-16177

Latest Information Update: 03 Apr 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Ildong Pharmaceutical
  • Developer Evotec SE; Ildong Pharmaceutical
  • Class Alkynes; Antihyperglycaemics; Carboxylic acids; Ethers; Fluorinated hydrocarbons; Furans; Indenes; Phenyl ethers; Pyridines; Small molecules
  • Mechanism of Action FFAR1 protein agonists; G protein-coupled receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Discontinued Type 2 diabetes mellitus

Most Recent Events

  • 03 Apr 2026 Chemical structure information (structure, chemical name, Molecular formula, CAS number) added.
  • 02 Apr 2026 Discontinued - Phase-I for Type 2 diabetes mellitus (Combination therapy) in Germany (PO) (Yunovia Pipeline, April 2026)
  • 02 Apr 2026 Discontinued - Phase-I for Type 2 diabetes mellitus (In volunteers) in Germany (PO) (Yunovia Pipeline, April 2026)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top